Loading...
Header Logo
Keywords
Last Name
Institution

HUA ZHAO

TitleAssociate Professor
InstitutionMD Anderson
DepartmentEpidemiology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Zhao H, Shen J, Moore SC, Ye Y, Wu X, Esteva FJ, Tripathy D, Chow WH. Breast cancer risk in relation to plasma metabolites among Hispanic and African American women. Breast Cancer Res Treat. 2019 Feb 15. PMID: 30771047.
      View in: PubMed
    2. Zhao H, Shen J, Hodges TR, Song R, Fuller GN, Heimberger AB. Serum microRNA profiling in patients with glioblastoma: a survival analysis. Mol Cancer. 2017 03 11; 16(1):59. PMID: 28284220.
      View in: PubMed
    3. Zhao H, Shen J, Hu Q, Davis W, Medico L, Wang D, Yan L, Guo Y, Liu B, Qin M, Nesline M, Zhu Q, Yao S, Ambrosone CB, Liu S. Effects of preanalytic variables on circulating microRNAs in whole blood. Cancer Epidemiol Biomarkers Prev. 2014 Dec; 23(12):2643-8. PMID: 25472672.
      View in: PubMed
    4. Romero Arenas MA, Fowler RG, San Lucas FA, Shen J, Rich TA, Grubbs EG, Lee JE, Scheet P, Perrier ND, Zhao H. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients. Surgery. 2014 Dec; 156(6):1351-7; discussion 1357-8. PMID: 25456907.
      View in: PubMed
    5. Shen J, Hu Q, Schrauder M, Yan L, Wang D, Medico L, Guo Y, Yao S, Zhu Q, Liu B, Qin M, Beckmann MW, Fasching PA, Strick R, Johnson CS, Ambrosone CB, Zhao H, Liu S. Circulating miR-148b and miR-133a as biomarkers for breast cancer detection. Oncotarget. 2014 Jul 30; 5(14):5284-94. PMID: 25051376.
      View in: PubMed
    6. Yao S, Graham K, Shen J, Campbell LE, Singh P, Zirpoli G, Roberts M, Ciupak G, Davis W, Hwang H, Khoury T, Bovbjerg DH, Jandorf L, Pawlish KS, Bandera EV, Liu S, Ambrosone CB, Zhao H. Genetic variants in microRNAs and breast cancer risk in African American and European American women. Breast Cancer Res Treat. 2013 Oct; 141(3):447-59. PMID: 24062209.
      View in: PubMed
    7. Peng M, Bakker JL, Dicioccio RA, Gille JJ, Zhao H, Odunsi K, Sucheston L, Jaafar L, Mivechi NF, Waisfisz Q, Ko L. Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers. Genes Cancer. 2013 Jan; 4(1-2):15-25. PMID: 23946868.
      View in: PubMed
    8. Zhao H, Shen J, Wang D, Guo Y, Gregory S, Medico L, Hu Q, Yan L, Odunsi K, Lele S, Liu S. Associations between gene expression variations and ovarian cancer risk alleles identified from genome wide association studies. PLoS One. 2012; 7(11):e47962. PMID: 23133607.
      View in: PubMed
    9. McCann SE, Liu S, Wang D, Shen J, Hu Q, Hong CC, Newman VA, Zhao H. Reduction of dietary glycaemic load modifies the expression of microRNA potentially associated with energy balance and cancer pathways in pre-menopausal women. Br J Nutr. 2013 Feb 28; 109(4):585-92. PMID: 22647265.
      View in: PubMed
    10. Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, Zhao H, Sucheston LE, Tang L, Roberts M, Ciupak G, Davis W, Hwang H, Johnson CS, Trump DL, McCann SE, Ademuyiwa F, Pawlish KS, Bandera EV, Ambrosone CB. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res. 2012 Apr 04; 14(2):R58. PMID: 22480149.
      View in: PubMed
    11. Hu Q, Wang D, Yan L, Zhao H, Liu S. VPA: an R tool for analyzing sequencing variants with user-specified frequency pattern. BMC Res Notes. 2012 Jan 14; 5:31. PMID: 22243673.
      View in: PubMed
    12. Shen J, Wang D, Gregory SR, Medico L, Hu Q, Yan L, Odunsi K, Lele SB, Ambrosone CB, Liu S, Zhao H. Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer. Carcinogenesis. 2012 Mar; 33(3):604-12. PMID: 22235027.
      View in: PubMed
    13. Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, DeLoia JA. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Mar; 124(3):575-81. PMID: 22112610.
      View in: PubMed
    14. Sucheston LE, Zhao H, Yao S, Zirpoli G, Liu S, Barlow WE, Moore HC, Thomas Budd G, Hershman DL, Davis W, Ciupak GL, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Livingston RB, Albain KS, Hayes DF, Ambrosone CB. Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221). Breast Cancer Res Treat. 2011 Dec; 130(3):993-1002. PMID: 21766209.
      View in: PubMed
    15. Yao S, Barlow WE, Albain KS, Choi JY, Zhao H, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF, Ravdin PM, Martino S, Lyss AP, Osborne CK, Abeloff M, Hortobagyi GN, Hayes DF, Ambrosone CB. Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer. Clin Cancer Res. 2010 Dec 15; 16(24):6169-76. PMID: 21169260.
      View in: PubMed
    16. Shen J, Medico L, Zhao H. Allelic imbalance in BRCA1 and BRCA2 gene expression and familial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2011 Jan; 20(1):50-6. PMID: 21119070.
      View in: PubMed
    17. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One. 2010 Oct 29; 5(10):e13735. PMID: 21060830.
      View in: PubMed
    18. Zhao H, Logothetis CJ, Gorlov IP. Usefulness of the top-scoring pairs of genes for prediction of prostate cancer progression. Prostate Cancer Prostatic Dis. 2010 Sep; 13(3):252-9. PMID: 20386565.
      View in: PubMed
    19. Zhao H, Shen J, Medico L, Platek M, Ambrosone CB. Length heteroplasmies in human mitochondrial DNA control regions and breast cancer risk. Int J Mol Epidemiol Genet. 2010 Apr 05; 1(3):184-92. PMID: 21537390.
      View in: PubMed
    20. Yao S, Barlow WE, Albain KS, Choi JY, Zhao H, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF, Ravdin PM, Martino S, Lyss AP, Osborne CK, Abeloff MD, Hortobagyi GN, Hayes DF, Ambrosone CB. Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer. Breast Cancer Res Treat. 2010 Nov; 124(2):433-9. PMID: 20309628.
      View in: PubMed
    21. Shen J, DiCioccio R, Odunsi K, Lele SB, Zhao H. Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC Cancer. 2010 Feb 18; 10:47. PMID: 20167074.
      View in: PubMed
    22. Shen J, Platek M, Mahasneh A, Ambrosone CB, Zhao H. Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion. 2010 Jan; 10(1):62-8. PMID: 19788937.
      View in: PubMed
    23. Shen J, Ambrosone CB, Zhao H. Novel genetic variants in microRNA genes and familial breast cancer. Int J Cancer. 2009 Mar 01; 124(5):1178-82. PMID: 19048628.
      View in: PubMed
    24. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T, Wu X. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res. 2008 Dec 01; 14(23):7956-62. PMID: 19047128.
      View in: PubMed
    25. Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 2008 Oct; 29(10):1963-6. PMID: 18660546.
      View in: PubMed
    26. Lin EH, Hassan M, Li Y, Zhao H, Nooka A, Sorenson E, Xie K, Champlin R, Wu X, Li D. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer. 2007 Aug 01; 110(3):534-42. PMID: 17594720.
      View in: PubMed
    27. Xing J, Spitz MR, Lu C, Zhao H, Yang H, Wang W, Stewart DJ, Wu X. Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2007 Jul; 16(7):1517-22. PMID: 17627019.
      View in: PubMed
    28. Zhao H, Lin J, Grossman HB, Hernandez LM, Dinney CP, Wu X. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer. 2007 May 15; 120(10):2208-13. PMID: 17290402.
      View in: PubMed
    29. Xing J, Zhu Y, Zhao H, Yang H, Chen M, Spitz MR, Wu X. Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):606-9. PMID: 17372259.
      View in: PubMed
    30. Shen J, Deininger P, Hunt JD, Zhao H. 8-Hydroxy-2'-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer. 2007 Feb 01; 109(3):574-80. PMID: 17154177.
      View in: PubMed
    31. Shen J, Deininger PL, Zhao H. Applications of computational algorithm tools to identify functional SNPs in cytokine genes. Cytokine. 2006 Jul; 35(1-2):62-6. PMID: 16919468.
      View in: PubMed
    32. Zhao H, Shen J, Deininger P, Hunt JD. Abasic sites and survival in resected patients with non-small cell lung cancer. Cancer Lett. 2007 Feb 08; 246(1-2):47-53. PMID: 16519994.
      View in: PubMed
    33. Lu C, Spitz MR, Zhao H, Dong Q, Truong M, Chang JY, Blumenschein GR, Hong WK, Wu X. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer. 2006 Jan 15; 106(2):441-7. PMID: 16342067.
      View in: PubMed
    34. Zhao H, Liang D, Grossman HB, Wu X. Glutathione peroxidase 1 gene polymorphism and risk of recurrence in patients with superficial bladder cancer. Urology. 2005 Oct; 66(4):769-74. PMID: 16230136.
      View in: PubMed
    35. Lin J, Kadlubar FF, Spitz MR, Zhao H, Wu X. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1832-6. PMID: 16030125.
      View in: PubMed
    36. Zhao H, Grossman HB, Delclos GL, Hwang LY, Troisi CL, Chamberlain RM, Chenoweth MA, Zhang H, Spitz MR, Wu X. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Cancer. 2005 Jul 01; 104(1):30-5. PMID: 15912517.
      View in: PubMed
    37. Gu J, Spitz MR, Zhao H, Lin J, Grossman HB, Dinney CP, Wu X. Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. Carcinogenesis. 2005 Oct; 26(10):1741-7. PMID: 15905204.
      View in: PubMed
    38. Saldivar SJ, Wang Y, Zhao H, Shao L, Lin J, Spitz MR, Wu X. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res. 2005 Apr 04; 582(1-2):71-8. PMID: 15781212.
      View in: PubMed
    39. Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res. 2005 Feb 15; 11(4):1408-15. PMID: 15746040.
      View in: PubMed
    40. Wu X, Roth JA, Zhao H, Luo S, Zheng YL, Chiang S, Spitz MR. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 2005 Jan 01; 65(1):349-57. PMID: 15665313.
      View in: PubMed
    41. Wu X, Zhao H, Suk R, Christiani DC. Genetic susceptibility to tobacco-related cancer. Oncogene. 2004 Aug 23; 23(38):6500-23. PMID: 15322521.
      View in: PubMed
    42. Wu X, Zhao H, Do KA, Johnson MM, Dong Q, Hong WK, Spitz MR. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3988-95. PMID: 15217929.
      View in: PubMed
    43. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8. PMID: 12928346.
      View in: PubMed
    44. Wu X, Tortolero-Luna G, Zhao H, Phatak D, Spitz MR, Follen M. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. Clin Cancer Res. 2003 Aug 15; 9(9):3356-61. PMID: 12960122.
      View in: PubMed
    45. Park SJ, Zhao H, Spitz MR, Grossman HB, Wu X. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res. 2003 Apr 20; 536(1-2):131-7. PMID: 12694753.
      View in: PubMed
    46. Wu X, Zhao H, Wei Q, Amos CI, Zhang K, Guo Z, Qiao Y, Hong WK, Spitz MR. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis. 2003 Mar; 24(3):505-9. PMID: 12663511.
      View in: PubMed
    47. Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003 Feb; 169(2):714-7. PMID: 12544349.
      View in: PubMed
    48. Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, Kadlubar FF, Spitz MR. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 01; 94(9):681-90. PMID: 11983757.
      View in: PubMed
    49. Zhao H, Spitz MR, Gwyn KM, Wu X. Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Mol Carcinog. 2002 Feb; 33(2):99-104. PMID: 11813302.
      View in: PubMed
    50. Plasma metabolomic profiles in breast cancer patients and healthy controls. Translational Oncology. 6:757-765.
    51. Mitochondrial DNA copy number in peripheral blood and melanoma risk. PLoS One. 10.
    52. Lifestyle predictors of oxidant and antioxidant enzyme activities and total antioxidant capacity in healthy women. Journal of Physiology and Biochemistry. 1-18.
    53. Genetic polymorphisms in genes related to risk-taking behaviours predicting body mass index trajectory among Mexican American adolescents. Pediatric obesity.
    54. Global methylation of blood leukocyte DNA and risk of melanoma. International Journal of Cancer.
    55. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes. Oncotarget. 7:20486-20495.
    56. Correction. PLoS One. 8.
    57. Mitochondrial DNA 4977-base pair common deletion in blood leukocytes and melanoma risk. Pigment Cell and Melanoma Research. 29:372-378.
    58. Mitochondrial DNA copy number in whole blood and glioma risk. Molecular Carcinogenesis.
    59. Assessment of the prognostic value of two common variants of BRCA1 and BRCA2 genes in ovarian cancer patients treated with cisplatin and paclitaxel. Frontiers in Oncology. 3 AUG.
    ZHAO's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description